Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen

Pharmazie

Volumn 62, Issue 2, 2007, Pages 133-137

  Elsayed, Mustafa M A ^a   Abdallah, O Y ^a   Naggar, V F ^a   Khalafallah, N M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHOLIC ACID; DEOXYCHOLATE SODIUM; DRUG CARRIER; ETHOSOME; KETOTIFEN; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IN VITRO STUDY; MALE; NONHUMAN; SKIN ABSORPTION;

ADMINISTRATION, TOPICAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EAR, EXTERNAL; HISTAMINE H1 ANTAGONISTS; KETOTIFEN; LIPOSOMES; MALE; PARTICLE SIZE; POLYSORBATES; RABBITS; SKIN; SURFACE-ACTIVE AGENTS;

EID: 33846933879     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.2.6082     Document Type: Article

References (42)

1. Ainbinder D, Touitou E (2005) Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 12: 297-303.
2. Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR (2003) Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56: 389-392.
3. Brockman H, Graff G, Spellman J, Yanni J (2000) A comparison of the effects of olopatadine and ketotifen on model membranes. Acta Ophthalmol Scand Suppl 10-15.
4. Brockman HL, Momsen MM, Knudtson JR, Miller ST, Graff G, Yanni JM (2003) Interactions of olopatadine and selected antihistamines with model and natural membranes. Ocul Immunol Inflamm 11: 247-268.
5. Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104: 226-232.
6. Cevc G, Blume G, Schatzlein A (1995) Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release 36: 3-16.
7. Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13: 257-388.
8. Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368: 201-215.
9. Cevc G, Blume G (2001) New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 1514: 191-205.
10. Cevc G, Schatzlein A, Richardsen H (2002) Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564: 21-30.
11. Cevc G (2003) Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42: 461-474.
12. Cevc G, Blume G (2003) Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim Biophys Acta 1614: 156-164.
13. Cevc G, Blume G (2004) Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663: 61-73.
14. Chiang CH, Chen JL, Liu YT, Wang DP (1998) Therapeutic effect and pharmacokinetics of ketotifen transdermal delivery system. Drug Dev Ind Pharm 24: 213-217.
15. Corbo M, Liu JC, Chien YW (1990) Bioavailability of propranolol following oral and transdermal administration in rabbits. J Pharm Sci 79: 584-587.
16. Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21: 1879-1885.
17. El Maghraby GM, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51: 1123-1134.
18. El Maghraby GM, Williams AC, Barry BW (2000a) Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196: 63-74.
19. El Maghraby GM, Williams AC, Barry BW (2000b) Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204: 159-169.
20. El Maghraby GM, Williams AC, Barry BW (2001a) Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 53: 1069-1077.
21. El Maghraby GM, Williams AC, Barry BW (2001b) Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol 53: 1311-1322.
22. Elsayed MM (2006) Development and validation of a rapid HPLC method for the determination of ketotifen in pharmaceuticals. Drug Dev Ind Pharm 32: 457-461.
23. Graff G, Miller ST, Yanni JM, Momsen MM, Brockman HL (2004) The effects of olopatadine, desloratadine, ketotifen, azelastine, and epinastine on membrane stability. J Allergy Clin Immunol 113: S328.
24. Guo J, Ping Q, Sun G, Jiao C (2000) Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm 194: 201-207.
25. Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, Kluft C, Crommelin DJ (1995) The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target 3: 301-310.
26. Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discovery Today: Technologies 2: 67-74.
27. Inoue K, Ogawa K, Suzuki Y, Okada J, Kusai A, Ikeda M, Nishimura K (2000) The skin permeation mechanism of ketotifen: evaluation of permeation pathways and barrier components in the stratum corneum. Drug Dev Ind Pharm 26: 45-53.
28. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Monkkonen J (1999) Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 7: 279-286.
29. Kitagawa S, Ikarashi A (2003) Enhanced skin permeation of cationic drug ketotifen through excised guinea pig dorsal skin by surfactants with different electric charges. Chem Pharm Bull 51: 1183-1185.
30. Kobayashi Y, Nakamura H, Sugibayashi K, Morimoto Y (1997) Estimation of action site of L-lactic acid-ethanol-isopropyl myristate mixed system for its enhancing effect on the skin permeation of ketotifen. Int J Pharm 156: 153-162.
31. Lee EH, Kim A, Oh YK, Kim CK (2005) Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26: 205-210.
32. Lee YL, Chiang CH, Chen JL (1994) In vitro and in vivo percutaneous absorption studies of ketotifen patches. Drug Dev Ind Pharm 20: 2965-2976.
33. Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM (2005) Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298: 1-12.
34. Nakamura H, Pongpaibul Y, Hayashi T, Sugibayashi K, Morimoto Y (1996) Effect of lipophilic multicomponent system on the skin permeation of ketotifen fumarate. Int J Pharm 141: 71-80.
35. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M (2005) Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 106: 99-110.
36. Paul A, Cevc G, Bachhawat BK (1995) Transdermal immunization with large proteins by means of ultradefonnable drug carriers. Eur J Immunol 25: 3521-3524.
37. Simoes SI, Tapadas JM, Marques CM, Cruz ME, Martins MB, Cevc G (2005) Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween®80. Eur J Pharm Sci 26: 307-317.
38. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65: 403-418.
39. Trotta M, Peira E, Debernardi F, Gallarate M (2002) Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241: 319-327.
40. Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270: 119-125.
41. Warner RR, Myers MC, Taylor DA (1988) Electron probe analysis of human skin: determination of the water concentration profile. J Invest Dermatol 90: 218-224.
42. Williams A (2003) Transdermal and topical drug delivery. First Ed., London.